Sign in

CIK 0001372299

  • Non-accelerated filer
  • Smaller reporting company

Ocugen, Inc.

Sign in to watch
Ticker
OCGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 484-328-4701
Business address
11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
Former names
HISTOGENICS CORP
  1. 4 Derivatives Options or other derivatives
  2. 4 Shares withheld for taxes See Remarks gave up 842 shares (to pay taxes)
  3. 4 Shares withheld for taxes Chief Scientific Officer gave up 917 shares (to pay taxes)
  4. 4 Open-market buy Director bought 200,278 shares at $0.50 ($99,999)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Shares withheld for taxes Chief Scientific Officer gave up 7,102 shares (to pay taxes)
  13. 4 Shares withheld for taxes CAO/SVP, Finance gave up 1,913 shares (to pay taxes)
  14. 4 Open-market sale Chief Executive Officer sold 100,000 shares at $1.08 ($108,000)
  15. 4 Open-market sale Chief Executive Officer sold 100,000 shares at $1.28 ($128,000)
  16. 4 Grant or award Chief Scientific Officer acquired 315,924 shares (grant or award)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Grant or award CAO/SVP, Finance acquired 122,951 shares (grant or award)
  19. 4 Grant or award Chief Executive Officer acquired 1,475,410 shares (grant or award)
  20. 4 Open-market sale Chief Executive Officer sold 95,809 shares at $1.43 ($137,007)

Page 3 of 15 · 288 filings